Full Text View
Tabular View
No Study Results Posted
Related Studies
BIBW 2992 (Afatinib) and Vinorelbine
This study is currently recruiting participants.
Verified February 2012 by University of Magdeburg
Study NCT01531764   Information provided by University of Magdeburg

First Received on February 9, 2012.   Last Updated on September 17, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Carcinoma Breast Stage IV
Additional conditions recognized in this trial
Breast Neoplasms
Carcinoma
More general conditions related to this trial
Breast Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Skin Diseases
Additional drug interventions recognized in this trial
Vinorelbine
More general drug interventions related to this trial
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of Magdeburg
Boehringer Ingelheim Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services